BlackRock
ARIA

BlackRock’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

BlackRock’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-16,920
Closed -$210K – 5135
2016
Q4 		$210K Sell
16,920
-2,234
-12% -$26.9K ﹤0.01% 2114
2016
Q3 		$263K Buy
19,154
+1,109
+6% +$11.1K ﹤0.01% 2010
2016
Q2 		$133K Buy
18,045
+6,474
+56% +$48.6K ﹤0.01% 2354
2016
Q1 		$74K Buy
11,571
+6,295
+119% +$35.3K ﹤0.01% 2155
2015
Q4 		$33K Buy
5,276
+868
+20% +$5.7K ﹤0.01% 2309
2015
Q3 		$25K Hold
4,408
– – ﹤0.01% 2266
2015
Q2 		$37K Sell
4,408
-403
-8% -$3.56K ﹤0.01% 2112
2015
Q1 		$40K Hold
4,811
– – ﹤0.01% 2050
2014
Q4 		$33K Hold
4,811
– – ﹤0.01% 2143
2014
Q3 		$26K Hold
4,811
– – ﹤0.01% 2214
2014
Q2 		$31K Sell
4,811
-5,322
-53% -$36.6K ﹤0.01% 2169
2014
Q1 		$81K Sell
10,133
-1,184
-10% -$9.22K ﹤0.01% 1767
2013
Q4 		$77K Sell
11,317
-24,866
-69% -$134K ﹤0.01% 1812
2013
Q3 		$666K Buy
36,183
+20,459
+130% +$397K ﹤0.01% 1177
2013
Q2 		$275K Buy
+15,724
New +$279K ﹤0.01% 1403

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

BlackRock's ARIA Position: Q1 2017 in Review

BlackRock sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 16,920 shares — an estimated $210K sold.

BlackRock first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $666K in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • BlackRock reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • BlackRock sold 16,920 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $210K.
  • BlackRock first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • BlackRock's Ariad Pharmaceuticals Inc position peaked at $666K in Q3 2013.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on BlackRock's 13F filing for Q1 2017, filed 12 May 2017.